Supplementary Methods, Supplementary References, Supplementary Tables 1-3, Supplementary Figures 1-4 from Androgen Receptor Variant AR-V9 Is Coexpressed with AR-V7 in Prostate Cancer Metastases and Predicts Abiraterone Resistance
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Table 1: Baseline Characteristics of the Patients; Supplementary Table 2: Baseline RNA-seq Expression Levels for AR/ARVs (spliced reads per million); Supplementary Table 3: TaqMan Gene Expression Assays with Circulating Tumor Cells; Supplementary Figure 1: Actinomycin D responses of AR-V9 and AR-V7 mRNA in 22Rv1 cells; Supplementary Figure 2: 3’ rapid amplification of cDNA ends (RACE) for single molecule real-time (SMRT) sequencing; Supplementary Figure 3: Purified AR-V9 polyclonal antibodies detect overexpressed AR-V9 in western blot with overexpressed AR-V9; Supplementary Figure 4: Relationship between tumor RNA p13 purity, AR-V7, and AR-V9 expression levels in CRPC metastases.
Authors: Manish Kohli, Yeung Ho, David W. Hillman, Jamie L. Van Etten, Christine Henzler, Rendong Yang, Jamie M. Sperger, Yingming Li, Elizabeth Tseng, Ting Hon, Tyson Clark, Winston Tan, Rachel E. Carlson, Liguo Wang, Hugues Sicotte, Ho Thai, Rafael Jimenez, Haojie Huang, Peter T. Vedell, Bruce W. Eckloff, Jorge F. Quevedo, Henry C. Pitot, Brian A. Costello, Jin Jen, Eric D. Wieben, Kevin A.T. Silverstein, Joshua M. Lang, Liewei Wang, Scott M. Dehm
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361922006